Mårten Segelmark
41 – 50 of 186
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
COVID-19 and ANCA-associated vasculitis : Recommendations for vaccine preparedness and the use of rituximab
(
- Contribution to journal › Letter
-
Mark
Venous thromboembolism in ANCA-associated vasculitis : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Treatment practices and outcomes in incident peritoneal dialysis patients : The Swedish Renal Registry 2006-2015
(
- Contribution to journal › Article
-
Mark
Mortaliteten hos svårt njursjuka var hög under covid 19-pandemin
(
- Contribution to journal › Article
- 2020
-
Mark
Serum levels and removal by haemodialysis and haemodiafiltration of tryptophan-derived uremic toxins in ESKD patients
(
- Contribution to journal › Article
-
Mark
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
(
- Contribution to journal › Scientific review
-
Mark
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
(
- Contribution to journal › Article
-
Mark
2020 international consensus on ANCA testing beyond systemic vasculitis
(
- Contribution to journal › Scientific review
-
Mark
Antiglomerular basement membrane disease
2020) p.4943-4950(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Serological testing in small vessel vasculitis
(
- Contribution to journal › Scientific review